Cidara Therapeutics Inc (NASDAQ: CDTX) stock closed at $17.45 on 11/21/24 after a major increase of 15.4%. Moreover, exceptionally high trading volume at 1523% of normal accompanied the advance. The stock has risen 25.5% during […]
Extremely significant negative changes in ASGN Inc (NYSE: ASGN) investment behavior have recently occurred: its longer term price trend turned down, its shorter term price trend turned down, and the stock fell on very heavy […]
Recent extremely meaningful negative changes in investment behavior have impacted Ultrapar Participacoes SA (NYSE: UGP): negative upside/downside volume developed, and the stock fell on very heavy volume. Ultrapar Participacoes SA (NYSE: UGP) has recently experienced […]
UGI Corp (NYSE: UGI) has reported a loss for its fourth fiscal quarter (ending September 30) of $-1.27 versus $0.62 for the same period a year ago — a decline of -305%. For the latest […]
The Cato Corp (NYSE: CATO) has reported a loss for its third fiscal quarter (ending October 31) of $-0.79 versus a loss $-0.30 for the same period a year ago — an increase of 163%. […]
Extremely significant negative changes in Target Corp (NYSE: TGT) investment behavior have recently occurred: its longer term price trend turned down, its shorter term price trend turned down, the stock fell on very heavy volume, […]
Pro Dex Inc (NASDAQ: PDEX) stock suffered a major decline of -11.1% on 11/21/24. The shares closed at $42.33. Trading volume in this decline was normal. The stock has been exceptionally strong relative to the […]
Matthews International Corp (NASDAQ: MATW) has reported a loss for its fourth fiscal quarter (ending September 30) of $-2.21 versus $0.57 for the same period a year ago — a decline of -488%. For the […]
Fonar Corp (NASDAQ: FONR) stock enjoyed a major increase of 10.5% on 11/21/24. The shares closed at $16.45. Moreover, trading volume in this advance was exceptionally high at 225% of normal. Relative to the market […]
For its first fiscal quarter (ending October 31), Copart Inc (NASDAQ: CPRT) has reported a 9% increase in E.P.S. from $0.35 a year ago to $0.38 in the current quarter. For the latest four quarters […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research